PyInvesting

Market research

002940.SHE Zhejiang AngLiKang Pharmaceutical CO.,LTD

SHE CNY Healthcare

Latest close

21.29 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
5B
P/E ratio
45.12
Analyst target
Not available
Dividend yield
0.6%
Beta
0.7

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 7 months ago

Zhejiang AngLiKang Pharmaceutical CO.,LTD is currently in a long term downtrend where the price is trading 10.7% below its 200 day moving average.

From a valuation standpoint, the stock is 72.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.7.

Zhejiang AngLiKang Pharmaceutical CO.,LTD's total revenue sank by 2.7% to $310M since the same quarter in the previous year.

Its net income has increased by 55.4% to $39M since the same quarter in the previous year.

Finally, its free cash flow grew by 49.7% to $45M since the same quarter in the previous year.

Based on the above factors, Zhejiang AngLiKang Pharmaceutical CO.,LTD gets an overall score of 3/5.